Clinical Trials on β-thalassemia Major in India
Total 28 results
-
Seasons Biotechnology (Taizhou) Co., Ltd.CompletedMajor Depressive Disorder (MDDIndia
-
Seasons Biotechnology (Taizhou) Co., Ltd.CompletedMajor Depressive Disorder (MDD)India
-
Seasons Biotechnology (Taizhou) Co., Ltd.CompletedSingle Dose Oral Bioequivalence Study of Vortioxetine Hemihydrobromide Orally Disintegrating TabletsMajor Depressive Disorder (MDD)India
-
Dr Gerard O'ReillyAll India Institute of Medical Sciences, New Delhi; Monash University; The Alfred and other collaboratorsCompletedMajor Trauma | Injuries MajorIndia
-
All India Institute of Medical Sciences, BhubaneswarCompletedMajor Depressive DisorderIndia
-
All India Institute of Medical Sciences, BhubaneswarCompletedMajor Depressive DisorderIndia
-
Government Medical College, BhavnagarHealth and Family Welfare Department, Government of Gujarat, India; Arjuna...Completed
-
CelgeneAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...RecruitingBeta-ThalassemiaUnited States, Turkey, Italy, Thailand, Germany, Greece, China, India, Lebanon
-
Teresa HowardAll India Institute of Medical Sciences, New Delhi; Monash University; The Alfred and other collaboratorsUnknown
-
Johns Hopkins UniversityJohns Hopkins Bloomberg School of Public Health; Chhatrapati Shahuji Maharaj...CompletedSchizophrenia | Bipolar Disorder | Major Depressive DisorderIndia
-
H. Lundbeck A/SCompletedMajor Depressive DisorderIndia
-
SanofiCompletedMajor Depressive DisorderFrance, Germany, Turkey, India, Malaysia, Taiwan, Belgium, Tunisia, Finland, Korea, Republic of, Morocco, Greece, Estonia
-
Targacept Inc.CompletedDepression | Major Depressive DisorderUnited States, India
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedMajor Depressive Disorder (MDD)United States, Spain, Hungary, South Africa, Croatia, France, Poland, India, Canada, Sweden, Malaysia
-
GlaxoSmithKlineTerminatedDepressive Disorder, MajorIndia, Russian Federation, Estonia
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedMajor Depressive Disorder (MDD)Finland, Germany, Korea, Republic of, United States, Taiwan, Estonia, India, Italy, Mexico
-
Otsuka Pharmaceutical Development & Commercialization...TerminatedMajor Depressive Disorder (MDD)United States, Australia, Bulgaria, Romania, India, Slovakia, Philippines
-
Intra-Cellular Therapies, Inc.CompletedMajor Depressive DisorderUnited States, Bulgaria, Czechia, Slovakia, Hungary, India
-
H. Lundbeck A/SCompletedMajor Depressive DisorderUkraine, Lithuania, France, Austria, Russian Federation, Australia, Belgium, Canada, Czech Republic, Finland, India, Korea, Republic of, Malaysia, Norway, Philippines, Serbia, Sweden
-
AstraZenecaTargacept Inc.CompletedDepression | Major Depressive DisorderUnited States, India
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedDepressive Disorder, MajorKorea, Republic of, India, China, Taiwan
-
Intra-Cellular Therapies, Inc.Enrolling by invitationMajor Depressive DisorderUnited States, Bulgaria, Czechia, Slovakia, Germany, Hungary, Poland, Finland, India, Korea, Republic of, Sweden
-
AstraZenecaTerminatedMajor Depressive DisorderUnited States, Estonia, Japan, Finland, India
-
AstraZenecaTargacept Inc.CompletedDepression | Major Depressive DisorderUnited States, India, Puerto Rico
-
OctapharmaCompletedPrevent Bleeding in Major SurgeryUnited States, Turkey, Romania, India, Bulgaria, Italy, Oman, Poland, South Africa
-
TakedaCompletedDepressive Disorder, MajorTaiwan, Germany, Hong Kong, Poland, Malaysia, Romania, Serbia, Ukraine, Japan, Finland, Latvia, Croatia, India, Korea, Republic of, Philippines, Russian Federation
-
Novartis PharmaceuticalsRecruitingAcute Myeloid Leukemia | Primary Myelofibrosis | Polycythemia Vera | Thalassemia | Graft Versus Host DiseaseKorea, Republic of, Italy, Belgium, Germany, Australia, Bulgaria, Chile, China, Denmark, Greece, Hungary, Israel, Lebanon, Poland, Portugal, Russian Federation, Slovakia, South Africa, Spain, Sweden, Thailand, India, Japan, Mexico, Turkey, Fran...